The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Jardiance

10 milligram(s) Film-coated tablet

Boehringer Ingelheim International GmbHEU/1/14/930/010-018

Main Information

Trade NameJardiance
Active SubstancesEmpagliflozin
Strength10 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberEU/1/14/930/010-018

Group Information

ATC CodeA10BX Other blood glucose lowering drugs, excl. insulins
A10BX12 empagliflozin

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back